The proposal would eliminate health-plan-run PBMs in Medicaid and establish a single state-contracted PBM, a move supporters ...
As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...
The Federal Trade Commission on Jan. 14 published a second interim staff report on the prescription drug middleman industry, ...
President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
According to the survey cited by NCPA, 60.4% of independent pharmacists are considering not stocking one or more of the first ...
It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...
10hon MSN
Iowa lawmakers introduce bills to stop Pharmacy Benefit Managers from giving pharmacies less money than it costs to fill prescriptions.
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback